Skip to main content
Explore URMC

menu

Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma

Research Question:
What are the side effects of adding two medications, ipilimumab and nivolumab, to radiation for your sarcoma?

Basic Study Information

Purpose:
Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma

Location: Cancer Center
Study Web URL:  https://clinicaltrials.gov/ct2/show/NCT03463408?term=USAR&rank=1
Study Reference #: USAR17101

Lead Researcher (Principal Investigator)

Lead Researcher: Deepak Sahasrabudhe, MD

Study Contact Information

Study Coordinator: Ayesha Khan
Phone: (585) 275-9319
Email: deepak_sahasrabudhe@urmc.rochester.edu

Additional Study Details

Learn More About These Conditions

More information about Sarcoma

Return to Search